CN113209160A - Oral ulcer gel and preparation method thereof - Google Patents

Oral ulcer gel and preparation method thereof Download PDF

Info

Publication number
CN113209160A
CN113209160A CN202110529278.8A CN202110529278A CN113209160A CN 113209160 A CN113209160 A CN 113209160A CN 202110529278 A CN202110529278 A CN 202110529278A CN 113209160 A CN113209160 A CN 113209160A
Authority
CN
China
Prior art keywords
gel
menthol
borneol
oil
oral ulcer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110529278.8A
Other languages
Chinese (zh)
Inventor
王进取
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Zhaoyao Health Industry Co ltd
Original Assignee
Yunnan Zhaoyao Health Industry Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yunnan Zhaoyao Health Industry Co ltd filed Critical Yunnan Zhaoyao Health Industry Co ltd
Priority to CN202110529278.8A priority Critical patent/CN113209160A/en
Publication of CN113209160A publication Critical patent/CN113209160A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/16Fluorine compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention belongs to the technical field of oral care, and particularly relates to an oral ulcer gel and a preparation method thereof; the method comprises the following raw materials: polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, menthol, borneol, chrysanthemum extract, baicalin, EDTA guar gum, clove basil oil, blumea balsamifera oil, glycerol and purified water; has the advantages of better repairing the oral ulcer and long-term preservation.

Description

Oral ulcer gel and preparation method thereof
Technical Field
The invention belongs to the technical field of oral care, and particularly relates to oral ulcer gel and a preparation method thereof.
Background
The oral cavity is the portal for microorganisms to enter respiratory tract, digestive tract and blood. Due to the special structural and physiological characteristics of the oral cavity, a complex microbial community is colonized in the oral cavity. The close and complex interactions between oral microflora, microbes and the host, normally maintain host health. If this ecological balance is broken, disease will be triggered. The oral microbiome is closely related to major diseases of the oral cavity and some systemic diseases. The frequently encountered diseases in oral cavity include dental caries, periodontal diseases (including gingivitis, periodontitis, etc.), oral mucosa diseases (oral ulcer, recurrent aphtha, lichen planus, cheilitis, etc.). These oral diseases are common diseases and frequently encountered diseases in the social population. With the progress and development of society and improvement of living standard of people, the understanding and the requirement of people on oral health are greatly improved, more and more people begin to pay attention to the oral health, and the awareness of oral health care is gradually enhanced.
Oral ulcer, commonly known as "aphtha", is a common ulcerative injury to the oral mucosa, which is usually found in the inner labial, tongue abdomen, buccal mucosa, vestibular sulcus, soft palate, etc., where the mucosa lacks cutinization layer or has poor keratosis. Tongue ulcer refers to oral ulcer occurring on tongue and tongue abdomen. The pain is severe when the oral ulcer is attacked, the local burning pain is obvious, and serious patients can influence diet and speaking, thereby causing great inconvenience to daily life; can be used for treating halitosis, chronic pharyngitis, constipation, headache, dizziness, nausea, asthenia, dysphoria, fever, and lymphadenectasis.
The oral cavity nursing gel is a thick liquid or semisolid preparation which is prepared by medicaments and auxiliary materials capable of forming gel and is in a uniform, suspension or emulsion type, and is a new oral cavity health nursing product after toothpaste, tooth powder and mouthwash.
Disclosure of Invention
The invention aims to provide oral ulcer gel and a preparation method thereof, which can better repair oral ulcer and can be stored for a long time.
In order to solve the technical problems, the invention adopts the following technical scheme:
the oral ulcer gel comprises the following raw materials: polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, menthol, borneol, chrysanthemum extract, baicalin, disodium EDTA, guar gum, clove basil oil, blumea balsamifera oil, glycerol and purified water.
Further, the feed comprises the following raw materials in percentage by mass: 1% of polyhexamethylene biguanide, 1% of carboxypropyltrimethylammonium chloride, 0.22% of sodium fluoride, 0.5% of ceramide, 0.5% of hyaluronic acid, 0.3% of menthol, 0.15% of borneol, 0.5% of chrysanthemum extract, 0.05% of baicalin, 0.03% of EDTA disodium, 0.03% of guar gum, 0.15% of clove basil oil, 0.15% of blumea balsamifera oil, 30% of glycerol and 66.42% of purified water.
The preparation method of the oral ulcer gel comprises the following steps:
s1, preparing the menthol and borneol inclusion complex: weighing borneol and menthol according to mass fraction, and then adding octenyl succinic acid starch sodium to prepare a volatile oil inclusion complex;
s2, weighing polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, chrysanthemum extract, baicalin, EDTA disodium, guar gum, clove basil oil, blumea balsamifera oil, glycerol, purified water and the inclusion compound prepared in the step S1 according to the proportion;
s3, adding the weighed guar gum and purified water into a sol-gel machine for soaking, stirring uniformly after soaking for a period of time, dissolving, adding polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride and EDTA disodium, and stirring for dissolving when the temperature is reduced to about 60 ℃;
s4, adding the mixture of oleum Ocimi Gratissimi, oleum Blumeae Balsamiferae, and S1 into glycerol, stirring, adding ceramide, flos Chrysanthemi extract, baicalin, and hyaluronic acid, and mixing;
s5, adding S4 into S3, and stirring to obtain the oral ulcer gel.
Further, in step S1, starch sodium octenyl succinate is added in an amount 3-5 times the weight of borneol and menthol.
Further, step S1 is carried out at a temperature of 55-65 ℃.
Compared with the prior art, the invention has at least one of the following beneficial effects:
1. the invention selects the raw materials with small stimulation and small side effect on human body, so that the prepared oral ulcer gel has better repairing effect on oral ulcer and smaller side effect on human body.
2. According to the invention, the blumea balsamifera oil and the clove basil oil are prepared, and then the menthol and the borneol are prepared into the menthol and borneol inclusion complex, so that more effective components can be extracted, and the storage time of the menthol and borneol inclusion complex can be prolonged.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Example 1
The oral ulcer gel comprises the following raw materials in percentage by mass: 1% of polyhexamethylene biguanide, 1% of carboxypropyltrimethylammonium chloride, 0.22% of sodium fluoride, 0.5% of ceramide, 0.5% of hyaluronic acid, 0.3% of menthol, 0.15% of borneol, 0.5% of chrysanthemum extract, 0.05% of baicalin, 0.03% of EDTA disodium, 0.03% of guar gum, 0.15% of clove basil oil, 0.15% of blumea balsamifera oil, 30% of glycerol and 66.42% of purified water;
the preparation method of the oral ulcer gel comprises the following steps:
s1, preparing the menthol and borneol inclusion complex: weighing borneol and menthol according to mass fraction, then adding starch sodium octenyl succinate to prepare a volatile oil inclusion complex, wherein the amount of the added starch sodium octenyl succinate is 3 times of the weight of the borneol and the menthol, and the step S1 is carried out at the temperature of 55 ℃;
s2, weighing polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, chrysanthemum extract, baicalin, EDTA disodium, guar gum, clove basil oil, blumea balsamifera oil, glycerol, purified water and the inclusion compound prepared in the step S1 according to the proportion;
s3, adding the weighed guar gum and purified water into a sol-gel machine for soaking, stirring uniformly after soaking for a period of time, dissolving, adding polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride and EDTA disodium, and stirring for dissolving when the temperature is reduced to about 60 ℃;
s4, adding the mixture of oleum Ocimi Gratissimi, oleum Blumeae Balsamiferae, and S1 into glycerol, stirring, adding ceramide, flos Chrysanthemi extract, baicalin, and hyaluronic acid, and mixing;
s5, adding S4 into S3, and stirring to obtain the oral ulcer gel.
Example 2
The oral ulcer gel comprises the following raw materials in percentage by mass: 1% of polyhexamethylene biguanide, 1% of carboxypropyltrimethylammonium chloride, 0.22% of sodium fluoride, 0.5% of ceramide, 0.5% of hyaluronic acid, 0.3% of menthol, 0.15% of borneol, 0.5% of chrysanthemum extract, 0.05% of baicalin, 0.03% of EDTA disodium, 0.03% of guar gum, 0.15% of clove basil oil, 0.15% of blumea balsamifera oil, 30% of glycerol and 66.42% of purified water;
the preparation method of the oral ulcer gel comprises the following steps:
s1, preparing the menthol and borneol inclusion complex: weighing borneol and menthol according to mass fraction, then adding starch sodium octenyl succinate to prepare a volatile oil inclusion complex, wherein the amount of the added starch sodium octenyl succinate is 3 times of the weight of the borneol and the menthol, and the step S1 is carried out at the temperature of 65 ℃;
s2, weighing polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, chrysanthemum extract, baicalin, EDTA disodium, guar gum, clove basil oil, blumea balsamifera oil, glycerol, purified water and the inclusion compound prepared in the step S1 according to the proportion;
s3, adding the weighed guar gum and purified water into a sol-gel machine for soaking, stirring uniformly after soaking for a period of time, dissolving, adding polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride and EDTA disodium, and stirring for dissolving when the temperature is reduced to about 60 ℃;
s4, adding the mixture of oleum Ocimi Gratissimi, oleum Blumeae Balsamiferae, and S1 into glycerol, stirring, adding ceramide, flos Chrysanthemi extract, baicalin, and hyaluronic acid, and mixing;
s5, adding S4 into S3, and stirring to obtain the oral ulcer gel.
Example 3
The oral ulcer gel comprises the following raw materials in percentage by mass: 1% of polyhexamethylene biguanide, 1% of carboxypropyltrimethylammonium chloride, 0.22% of sodium fluoride, 0.5% of ceramide, 0.5% of hyaluronic acid, 0.3% of menthol, 0.15% of borneol, 0.5% of chrysanthemum extract, 0.05% of baicalin, 0.03% of EDTA disodium, 0.03% of guar gum, 0.15% of clove basil oil, 0.15% of blumea balsamifera oil, 30% of glycerol and 66.42% of purified water;
the preparation method of the oral ulcer gel comprises the following steps:
s1, preparing the menthol and borneol inclusion complex: weighing borneol and menthol according to mass fraction, then adding starch sodium octenyl succinate to prepare a volatile oil inclusion complex, wherein the amount of the added starch sodium octenyl succinate is 5 times of the weight of the borneol and the menthol, and the step S1 is carried out at the temperature of 65 ℃;
s2, weighing polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, chrysanthemum extract, baicalin, EDTA disodium, guar gum, clove basil oil, blumea balsamifera oil, glycerol, purified water and the inclusion compound prepared in the step S1 according to the proportion;
s3, adding the weighed guar gum and purified water into a sol-gel machine for soaking, stirring uniformly after soaking for a period of time, dissolving, adding polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride and EDTA disodium, and stirring for dissolving when the temperature is reduced to about 60 ℃;
s4, adding the mixture of oleum Ocimi Gratissimi, oleum Blumeae Balsamiferae, and S1 into glycerol, stirring, adding ceramide, flos Chrysanthemi extract, baicalin, and hyaluronic acid, and mixing;
s5, adding S4 into S3, and stirring to obtain the oral ulcer gel.
Example 4
The oral ulcer gel comprises the following raw materials in percentage by mass: 1% of polyhexamethylene biguanide, 1% of carboxypropyltrimethylammonium chloride, 0.22% of sodium fluoride, 0.5% of ceramide, 0.5% of hyaluronic acid, 0.3% of menthol, 0.15% of borneol, 0.5% of chrysanthemum extract, 0.05% of baicalin, 0.03% of EDTA disodium, 0.03% of guar gum, 0.15% of clove basil oil, 0.15% of blumea balsamifera oil, 30% of glycerol and 66.42% of purified water;
the preparation method of the oral ulcer gel comprises the following steps:
s1, preparing the menthol and borneol inclusion complex: weighing borneol and menthol according to mass fraction, then adding starch sodium octenyl succinate to prepare a volatile oil inclusion complex, wherein the amount of the added starch sodium octenyl succinate is 4 times of the weight of the borneol and the menthol, and the step S1 is carried out at the temperature of 60 ℃;
s2, weighing polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, chrysanthemum extract, baicalin, EDTA disodium, guar gum, clove basil oil, blumea balsamifera oil, glycerol, purified water and the inclusion compound prepared in the step S1 according to the proportion;
s3, adding the weighed guar gum and purified water into a sol-gel machine for soaking, stirring uniformly after soaking for a period of time, dissolving, adding polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride and EDTA disodium, and stirring for dissolving when the temperature is reduced to about 60 ℃;
s4, adding the mixture of oleum Ocimi Gratissimi, oleum Blumeae Balsamiferae, and S1 into glycerol, stirring, adding ceramide, flos Chrysanthemi extract, baicalin, and hyaluronic acid, and mixing;
s5, adding S4 into S3, and stirring to obtain the oral ulcer gel.
Example 5
The oral ulcer gel comprises the following raw materials in percentage by mass: 1% of polyhexamethylene biguanide, 1% of carboxypropyltrimethylammonium chloride, 0.22% of sodium fluoride, 0.5% of ceramide, 0.5% of hyaluronic acid, 0.3% of menthol, 0.15% of borneol, 0.5% of chrysanthemum extract, 0.05% of baicalin, 0.03% of EDTA disodium, 0.03% of guar gum, 0.15% of clove basil oil, 0.15% of blumea balsamifera oil, 30% of glycerol and 66.42% of purified water;
the preparation method of the oral ulcer gel comprises the following steps:
s1, preparing the menthol and borneol inclusion complex: weighing borneol and menthol according to mass fraction, then adding starch sodium octenyl succinate to prepare a volatile oil inclusion complex, wherein the amount of the added starch sodium octenyl succinate is 5 times of the weight of the borneol and the menthol, and the step S1 is carried out at the temperature of 55 ℃;
s2, weighing polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, chrysanthemum extract, baicalin, EDTA disodium, guar gum, clove basil oil, blumea balsamifera oil, glycerol, purified water and the inclusion compound prepared in the step S1 according to the proportion;
s3, adding the weighed guar gum and purified water into a sol-gel machine for soaking, stirring uniformly after soaking for a period of time, dissolving, adding polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride and EDTA disodium, and stirring for dissolving when the temperature is reduced to about 60 ℃;
s4, adding the mixture of oleum Ocimi Gratissimi, oleum Blumeae Balsamiferae, and S1 into glycerol, stirring, adding ceramide, flos Chrysanthemi extract, baicalin, and hyaluronic acid, and mixing;
s5, adding S4 into S3, and stirring to obtain the oral ulcer gel.
Experimental analysis:
first, animal safety and effectiveness experiment
Subject: selecting 70 guinea pigs, anesthetizing, burning 60S under the tongue of the mice with a cotton ball stained with phenol solution to prepare ulcer surfaces with diameter of 5mm, and randomly dividing into 1-5 groups of experimental group and 1-2 groups of control group, each group containing 10 mice;
the administration method comprises the following steps: experimental groups 1 to 5 groups applied the oral ulcer gel prepared in examples 1 to 5 twice a day, 1mg each time, for 5 days continuously; the control group is coated with saline solution twice a day, 1mg each time, and continuously for 5 days;
evaluation of the effects: 0 degree: no ulcer under tongue; degree I: the ulcer exists, and no false membrane is obvious at the ulcer part; II degree: a layer of yellowish white thin false membrane is arranged on the surface of the ulcer part; and III degree: the thick false membrane is arranged on the surface of the ulcer, and inflammatory edema is formed around the ulcer; IV degree: the ulcer surface is thick pseudo-membrane, and inflammatory edema around the ulcer is serious.
And (3) analyzing an experimental result: the effect evaluation statistics are carried out after 5 days of the experiment, and the statistical results are shown in table 1:
0 degree Degree I II degree Degree III Degree of IV
Experimental group 1 8 2
Experimental group 2 9 1
Experimental group 3 10 0
Experimental group 4 8 1 1
Experimental group 5 9 1
Control group 1 1 2 2 5
Control group 2 1 1 1 6 1
As can be seen from Table 1, the oral ulcer gel of the present invention has a better repairing effect on oral ulcers.
Second, shelf life test
Subject: experimental groups: inventive examples 1-5 prepared oral ulcer gels;
control group: prepared according to the formulation and method of examples 1-5 of the present invention (except that menthol and borneol were not prepared into an inclusion, but were used directly) to obtain the oral ulcer gels of control groups 1-5;
the experimental process comprises the following steps: the oral ulcer gels of the experimental groups 1 to 5 and the oral ulcer gels prepared in the control groups 1 to 5 were placed in an open container and stored for 3 months, and the mass fraction of menthol was measured by gas chromatography at 15 days, 30 days, 45 days, 60 days, and 90 days, and the measurement results are shown in table 2:
15 days/%) 30 days/%) 45 days/%) 60 days/%) 90 days/%)
Experimental group 1 0.29% 0.28% 0.26% 0.24% 0.20%
Experimental group 2 0.29% 0.27% 0.26% 0.24% 0.22%
Experimental group 3 0.29% 0.28% 0.26% 0.24% 0.20%
Experimental group 4 0.29% 0.26% 0.25% 0.24% 0.19%
Experimental group 5 0.29% 0.28% 0.26% 0.24% 0.20%
Control group 1 0.26% 0.22% 0.18% 0.17% 0.14%
Control group 2 0.27% 0.22% 0.19% 0.17% 0.13%
Control group 3 0.29% 0.22% 0.18% 0.17% 0.15%
Control group 4 0.26% 0.20% 0.18% 0.15% 0.14%
Control group 5 0.26% 0.21% 0.18% 0.16% 0.13%
As can be seen from Table 2, the present invention has a good effect of preserving the beneficial ingredients, and the beneficial ingredients are less volatile and can be preserved for a long time.
Although the invention has been described herein with reference to a number of illustrative embodiments thereof, it should be understood that numerous other modifications and embodiments can be devised by those skilled in the art that will fall within the spirit and scope of the principles of this disclosure. More specifically, various variations and modifications are possible in the component parts and/or arrangements of the subject combination arrangement within the scope of the disclosure and claims of this application. In addition to variations and modifications in the component parts and/or arrangements, other uses will also be apparent to those skilled in the art.

Claims (5)

1. A dental ulcer gel characterized by: the method comprises the following raw materials: polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, menthol, borneol, chrysanthemum extract, baicalin, disodium EDTA, guar gum, clove basil oil, blumea balsamifera oil, glycerol and purified water.
2. The ulcerative stomatitis gel of claim 1, wherein: the material comprises the following raw materials in percentage by mass: 1% of polyhexamethylene biguanide, 1% of carboxypropyltrimethylammonium chloride, 0.22% of sodium fluoride, 0.5% of ceramide, 0.5% of hyaluronic acid, 0.3% of menthol, 0.15% of borneol, 0.5% of chrysanthemum extract, 0.05% of baicalin, 0.03% of EDTA disodium, 0.03% of guar gum, 0.15% of clove basil oil, 0.15% of blumea balsamifera oil, 30% of glycerol and 66.42% of purified water.
3. The method for preparing a gel for oral ulcer according to claim 1 or 2, wherein: the method comprises the following steps:
s1, preparing the menthol and borneol inclusion complex: weighing borneol and menthol according to mass fraction, and then adding octenyl succinic acid starch sodium to prepare a volatile oil inclusion complex;
s2, weighing polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride, ceramide, hyaluronic acid, chrysanthemum extract, baicalin, EDTA disodium, guar gum, clove basil oil, blumea balsamifera oil, glycerol, purified water and the inclusion compound prepared in the step S1 according to the proportion;
s3, adding the weighed guar gum and purified water into a sol-gel machine for soaking, stirring uniformly after soaking for a period of time, dissolving, adding polyhexamethylene biguanide, carboxypropyltrimethylammonium chloride, sodium fluoride and EDTA disodium, and stirring for dissolving when the temperature is reduced to about 60 ℃;
s4, adding the mixture of oleum Ocimi Gratissimi, oleum Blumeae Balsamiferae, and S1 into glycerol, stirring, adding ceramide, flos Chrysanthemi extract, baicalin, and hyaluronic acid, and mixing;
s5, adding S4 into S3, and stirring to obtain the oral ulcer gel.
4. The method of preparing a gel for oral ulcer according to claim 3, wherein: in step S1, the amount of starch sodium octenyl succinate added is 3-5 times of the weight of Borneolum Syntheticum and Mentholum.
5. The method of preparing a gel for oral ulcer according to claim 3, wherein: step S1 is performed at a temperature of 55-65 ℃.
CN202110529278.8A 2021-05-14 2021-05-14 Oral ulcer gel and preparation method thereof Pending CN113209160A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110529278.8A CN113209160A (en) 2021-05-14 2021-05-14 Oral ulcer gel and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110529278.8A CN113209160A (en) 2021-05-14 2021-05-14 Oral ulcer gel and preparation method thereof

Publications (1)

Publication Number Publication Date
CN113209160A true CN113209160A (en) 2021-08-06

Family

ID=77092031

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110529278.8A Pending CN113209160A (en) 2021-05-14 2021-05-14 Oral ulcer gel and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113209160A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1238946A (en) * 1998-06-15 1999-12-22 贵州宏宇药业有限公司 Liquid spray for treating oral and throat diseases and its preparing process
CN1814253A (en) * 2005-11-23 2006-08-09 上海华拓医药科技发展有限公司 Heat-sensitive gel preparation and preparing method
CN105796865A (en) * 2014-12-30 2016-07-27 桂林三金药业股份有限公司 Lozenge for clearing heat from throat and preparation method thereof
CN106265941A (en) * 2015-06-04 2017-01-04 上海市同济医院 A kind of Chinese medicine composition for treating oral ulcer and its oral cavity disintegration tablet and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1238946A (en) * 1998-06-15 1999-12-22 贵州宏宇药业有限公司 Liquid spray for treating oral and throat diseases and its preparing process
CN1814253A (en) * 2005-11-23 2006-08-09 上海华拓医药科技发展有限公司 Heat-sensitive gel preparation and preparing method
CN105796865A (en) * 2014-12-30 2016-07-27 桂林三金药业股份有限公司 Lozenge for clearing heat from throat and preparation method thereof
CN106265941A (en) * 2015-06-04 2017-01-04 上海市同济医院 A kind of Chinese medicine composition for treating oral ulcer and its oral cavity disintegration tablet and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
李传真: "冰片薄荷脑溶液治疗口腔溃疡", 《山西中医》 *
邢志敏,等: "复方黄芩含漱液用于重症患者口腔护理", 《航空航天医药》 *

Similar Documents

Publication Publication Date Title
CN107998036A (en) A kind of toothpaste and its manufacture method for oral cavity synthtic price index
CN107184476A (en) A kind of antibacterial mouthwash and preparation method thereof
Al Habashneh et al. The effect of a triclosan/copolymer/fluoride toothpaste on plaque formation, gingivitis, and dentin hypersensitivity: A single-blinded randomized clinical study
CN104644460A (en) Medicinal toothpaste composition and preparation method and application thereof
CN112691057B (en) Compound efficacy toothpaste and preparation method thereof
CN111686035A (en) Bio-enzyme antibacterial anti-allergy toothpaste
CN107811890A (en) A kind of oral cavity caring toothpaste composition
RU2286764C1 (en) Agent of prolonged action for treatment of mouth cavity inflammation diseases
Newman et al. Slow release metronidazole and a simplified mechanical oral hygiene regimen in the control of chronic periodontitis
CN111249289A (en) Oral care product or medicament for anti-inflammation and/or anti-allergy
CN112426376B (en) Mouthwash and preparation method thereof
CN107049828A (en) A kind of anti-caries toothpaste and preparation method thereof
Wolff et al. Effect of toothbrushing with 0.4% stannous fluoride and 0.22% sodium fluoride gel on gingivitis for 18 months
US5167952A (en) Therapeutic composition formulated as a dental rinse that stimulates Prostaglandin synthesis in the mouth to prevent plaque buildup on the teeth and Periodontal disease
CN111956682A (en) A butyrum-boron cream for treating stomatitis and gingivitis, and its preparation method and application
CN113209160A (en) Oral ulcer gel and preparation method thereof
CN111888285A (en) Swallowable toothpaste and preparation method thereof
CN113577098B (en) Application of magnesium hydride in preparation of composition for preventing and treating chronic periodontitis and magnesium hydride toothpaste
CN113318057B (en) Old people nursing toothpaste and preparation method and application thereof
CN1173323A (en) Composition for enhancing oral hygiene
Mushtaq et al. Comparative evaluation of 1% metformin gel as an adjunct to scaling and root planing in the treatment of chronic periodontitis with scaling and root planing alone: A randomized controlled clinical trial
Kleinberg et al. Effects of fluoride on the metabolism of the mixed oral flora
CN114159500A (en) Hyaluronic acid essential oil composition for nourishing and repairing oral cavity and application thereof
CN112220707A (en) Tooth sensitivity resisting biological lysozyme toothpaste composition
CN109432213B (en) Active composition of oral products, preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210806